McGuffin, P, Katz, R, Watkins, S, Rutherford, J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch Gen Psychiatry
1996; 53: 129–36.
Verhagen, M, van der Meij, A, van Deurzen, PA, Janzing, JG, Arias-Vasquez, A, Buitelaar, JK, et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry
2010; 15: 260–71.
Maisonpierre, PC, Belluscio, L, Friedman, B, Alderson, RF, Wiegand, SJ, Furth, ME, et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron
1990; 5: 501–9.
McAllister, AK, Katz, LC, Lo, DC. Neurotrophins and synaptic plasticity. Annu Rev Neurosci
1999; 22: 295–318.
Duman, RS, Monteggia, LM. A neurotrophic model for stress related mood disorders. Biol Psychiatry
2006; 59: 1116–27.
Conner, JM, Lauterborn, JC, Yan, Q, Gall, CM, Varon, S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci
1997; 17: 2295–313.
Pezawas, L, Verchinski, BA, Mattay, VS, Callicott, JH, Kolachana, BS. The brain-derived neurotrophic factor Val66Met polymorphism and variants in human cortical morphology. J Neurosci
2004; 24: 10099–102.
Montag, C, Weber, B, Fliessbach, K, Elger, C, Reuter, M. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol Med
2009; 39: 1831–9.
Schofield, PR, Williams, LM, Paul, RH, Gatt, JM, Brown, K, Luty, A, et al. Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems. Biol Psychol
2009; 80: 176–88.
Frodl, T, Schule, C, Schmitt, G, Born, C, Baghai, T, Zill, P, et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry
2007; 64: 410–6.
Nemoto, K, Ohnishi, T, Mori, T, Moriguchi, Y, Hashimoto, R, Asada, T, et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett
2006; 397: 25–9.
Gerritsen, L, Tendolkar, I, Franke, B, Vasquez, AA, Kooijman, S, Buitelaar, J, et al. BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects. Mol Psychiatry
2012; 17: 597–603.
Cardoner, N, Soria, V, Gratacos, M, Hernández-Ribas, R, Pujol, J, Lopez-Sola, M, et al. Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome. Depress Anxiety
2013; 30: 225–33.
Gonul, AS, Kitis, O, Eker, MC, Eker, OD, Ozan, E, Coburn, K. Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. World J Biol Psychiatry
2011; 12: 110–8.
Kanellopoulos, D, Gunning, FM, Morimoto, SS, Hoptman, MJ, Murphy, CF, Kelly, RE, et al. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. Am J Geriatr Psychiatry
2011; 19: 13–22.
Cole, J, Weinberger, DR, Mattay, VS, Cheng, X, Toga, AW, Thompson, PM, et al. No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes Brain Behav
2011; 10: 756–64.
Montag, C, Schoene-Bake, JC, Faber, J, Reuter, M, Weber, B. Genetic variation on the BDNF gene is not associated with differences in white matter tracts in healthy humans measured by tract-based spatial statistics. Genes Brain Behav
2010; 9: 886–91.
Carballedo, A, Amico, F, Ugwu, I, Fagan, AJ, Fahey, C, Morris, D, et al. Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype. Am J Med Genet B Neuropsychiatr Genet
2012; 159B: 537–48.
Panizzon, MS, Fennema-Notestine, C, Eyler, LT, Jernigan, TL, Prom-Wormley, E, Neale, M, et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex
2009; 19: 2728–35.
Yang, X, Liu, P, Sun, J, Wang, G, Zeng, F, Yuan, K, et al. Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults. PLoS One
2012; 7: e37777.
Cohen-Woods, S, Gaysina, D, Craddock, N, Farmer, A, Gray, J, Gunasinghe, C, et al. Depression case control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder. Hum Mol Genet
2009; 18: 1504–9.
Wing, JK, Babor, T, Brugha, T, Burke, J, Cooper, J, Giel, R, et al. SCAN: schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry
1990; 47: 589–93.
Wechsler, D. Wechsler Abbreviated Scale of Intelligence.
Psychological Corporation, 1999.
Beck, AT, Steer, RA, Brown, GK. Beck Depression Inventory.
Psychological Corporation, 1993.
Spielberger, CD, Gorsuch, RL, Lushene, R, Vagg, PR, Jacobs, GA. Manual for the State-Trait Anxiety Inventory.
Consulting Psychologists Press, 1983.
Jack, CR, Bernstein, MA, Fox, NC, Thompson, P, Alexander, G, Harvey, D, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging
2008; 27: 685–91.
Benjamini, Y, Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B
1995; 57: 289–300.
Bora, E, Fornito, A, Pantelis, C, Yucel, M. Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J Affect Dis
2012; 138: 9–18.
Castren, E, Voikar, V, Rantamaki, T. Role of neurotrophic factors in depression. Curr Opin Pharmacol
2007; 7: 18–21.
Fu, CHY, Steiner, H, Costafreda, SG. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis
2013; 52: 75–83.
Costafreda, SG, Chu, C, Ashburner, J, Fu, CHY. Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS One
2009; 4: e6353.
Rakic, P. Specification of cerebral cortical areas. Science
1988; 241: 170–6.
Koolschijn, PC, Crone, EA. Sex differences and structural brain maturation from childhood to early adulthood. Dev Cogn Neurosci
2013; 5: 106–18.
Hogstrom, LJ, Westlye, LT, Walhovd, KB, Fjell, AM. The structure of the cerebral cortex across adult life: age-related patterns of surface area, thickness, and gyrification. Cereb Cortex
2013; 23: 2521–30.
Matsuo, K, Walss-Bass, C, Nery, FG, Nicoletti, MA, Hatch, JP, Frey, BN. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmol
2009; 34: 1904–13.
Ho, BC, Milev, P, O'Leary, DS, Librant, A, Andreasen, NC, Wassink, TH. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry
2006; 63: 731–40.
Kawashima, K, Ikeda, M, Kishi, T, Kitajima, T, Yamanouchi, Y, Kinoshita, Y, et al. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophr Res
2009; 112: 72–9.
Montag, C, Reuter, M, Newport, B, Elger, C, Weber, B. The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. Neuroimage
Gasic, GP, Smoller, JW, Perlis, RH, Sun, M, Lee, S, Kim, BW. BDNF, relative preference, and reward circuitry responses to emotional communication. Am J Med Genet B Neuropsychiatr Genet
2009; 150B: 762–81.
Hariri, AR, Goldberg, TE, Mattay, VS, Kolachana, BS, Callicott, JH, Egan, MF. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci
2003; 23: 6690–4.
Hashimoto, R, Moriguchi, Y, Yamashita, F, Mori, T, Nemoto, K, Okada, T. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neurosci Res
2008; 61: 360–7.
Drevets, WC, Price, JL, Furey, ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct
2008; 213: 93–118.
Grieve, SM, Korgaonkar, MS, Koslow, SH, Gordon, E, Williams, LM. Widespread reductions in gray matter volume in depression. Neuroimage Clin
2013; 3: 332–9.
Li, Z, Zhang, Y, Wang, Z, Chen, J, Fan, J, Guan, Y, et al. The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice. J Psychiatr Res
2013; 47: 8–14.
Gatt, JM, Nemeroff, CB, Dobson-Stone, C, Paul, RH, Bryant, RA, Schofield, PR, et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry
2009; 14: 681–95.
Schmidt, HD, Duman, DS. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmol
2010; 35: 2378–91.
Licinio, J, Dong, C, Wong, ML. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry
2009; 66: 488–97.
Van Eijndhoven, P, van Wingen, G, Katzenbauer, M, Groen, W, Tepest, R, Fernandez, G, et al. Paralimbic cortical thickness in first-episode depression: evidence for trait-related differences in mood regulation. Am J Psychiatry
2013; 170: 1477–86.